| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9308286 | Kidney International | 2005 | 5 Pages |
Abstract
We conclude that the highly renoprotective capacity of mesenchymal stem cells opens the possibility for a cell-based paradigm shift in the treatment of I/R ARF.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Claudia Lange, Florian Tögel, Harald Ittrich, Frederic Clayton, Claus Nolte-Ernsting, Axel R. Zander, Christof Westenfelder,